OBJECTIVE: Recently, lymphoblastoid cell lines (LCLs) have emerged as an innovative model system for mapping gene variants that predict the dose response to chemotherapy drugs. METHODS: In the current study, this strategy was expanded to the in-vitro genome-wide association approach, using 516 LCLs derived from a White cohort to assess the cytotoxic response to temozolomide. RESULTS: Genome-wide association analysis using ∼2.1 million quality-controlled single-nucleotide polymorphisms (SNPs) identified a statistically significant association (P<10(-8)) with SNPs in the O(6)-methylguanine-DNA methyltransferase (MGMT) gene. We also show that the primary SNP in this region is significantly associated with the differential gene expression of MGMT (P<10(-26)) in LCLs and differential methylation in glioblastoma samples from The Cancer Genome Atlas. CONCLUSION: The previously documented clinical and functional relationships between MGMT and temozolomide response highlight the potential of well-powered genome-wide association studies of the LCL model system to identify meaningful genetic associations.
OBJECTIVE: Recently, lymphoblastoid cell lines (LCLs) have emerged as an innovative model system for mapping gene variants that predict the dose response to chemotherapy drugs. METHODS: In the current study, this strategy was expanded to the in-vitro genome-wide association approach, using 516 LCLs derived from a White cohort to assess the cytotoxic response to temozolomide. RESULTS: Genome-wide association analysis using ∼2.1 million quality-controlled single-nucleotide polymorphisms (SNPs) identified a statistically significant association (P<10(-8)) with SNPs in the O(6)-methylguanine-DNA methyltransferase (MGMT) gene. We also show that the primary SNP in this region is significantly associated with the differential gene expression of MGMT (P<10(-26)) in LCLs and differential methylation in glioblastoma samples from The Cancer Genome Atlas. CONCLUSION: The previously documented clinical and functional relationships between MGMT and temozolomide response highlight the potential of well-powered genome-wide association studies of the LCL model system to identify meaningful genetic associations.
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Geoffrey P Margison; Jim Heighway; Steven Pearson; Gail McGown; Mary R Thorncroft; Amanda J Watson; Kathryn L Harrison; Sarah J Lewis; Klaus Rohde; Philip V Barber; Paul O'Donnell; Andrew C Povey; Mauro F Santibáñez-Koref Journal: Carcinogenesis Date: 2005-04-14 Impact factor: 4.944
Authors: Joel A Simon; Feng Lin; Stephen B Hulley; Patricia J Blanche; David Waters; Stephen Shiboski; Jerome I Rotter; Deborah A Nickerson; Huiying Yang; Mohammed Saad; Ronald M Krauss Journal: Am J Cardiol Date: 2006-01-27 Impact factor: 2.778
Authors: Monika E Hegi; Lili Liu; James G Herman; Roger Stupp; Wolfgang Wick; Michael Weller; Minesh P Mehta; Mark R Gilbert Journal: J Clin Oncol Date: 2008-09-01 Impact factor: 44.544
Authors: Randall C Johnson; George W Nelson; Jennifer L Troyer; James A Lautenberger; Bailey D Kessing; Cheryl A Winkler; Stephen J O'Brien Journal: BMC Genomics Date: 2010-12-22 Impact factor: 3.969
Authors: Chad Brown; Tammy M Havener; Lorraine Everitt; Howard McLeod; Alison A Motsinger-Reif Journal: Front Genet Date: 2011-12-14 Impact factor: 4.599
Authors: John Jack; Tammy M Havener; Howard L McLeod; Alison A Motsinger-Reif; Matthew Foster Journal: Pharmacogenomics Date: 2015-08-28 Impact factor: 2.533
Authors: Chad C Brown; Tammy M Havener; Marisa W Medina; John R Jack; Ronald M Krauss; Howard L McLeod; Alison A Motsinger-Reif Journal: Pharmacogenomics Date: 2014-02 Impact factor: 2.533
Authors: Joice Kuroiwa-Trzmielina; Fan Wang; Robert W Rapkins; Robyn L Ward; Daniel D Buchanan; Aung Ko Win; Mark Clendenning; Christophe Rosty; Melissa C Southey; Ingrid M Winship; John L Hopper; Mark A Jenkins; Jake Olivier; Nicholas J Hawkins; Megan P Hitchins Journal: Clin Cancer Res Date: 2016-06-07 Impact factor: 12.531
Authors: Michael T Eadon; Heather E Wheeler; Amy L Stark; Xu Zhang; Erika L Moen; Shannon M Delaney; Hae Kyung Im; Patrick N Cunningham; Wei Zhang; M Eileen Dolan Journal: Hum Mol Genet Date: 2013-05-29 Impact factor: 6.150